Work

Persistent IDH mutations are not associated with increased relapse or death in patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide

Year: 2024

Type: article

Source: Bone Marrow Transplantation

DOI: 10.1038/s41409-023-02189-9

Authors: Niveditha Ravindra, Laura W. Dillon, Gege Gui, Matthew Smith, Lukasz P. Gondek, Richard J. Jones, Adam Corner, Christopher S. Hourigan, Alexander J. Ambinder

Institutions: National Institutes of Health, National Heart, Lung, and Blood Institute, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Bio-Rad (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Health and Human Services, National Heart, Lung, and Blood Institute, National Cancer Institute

Awards: Bone Marrow Transplantation in Human Disease, G3816216478, G4156671139, G5003200080, Detection, prevention and treatment of acute myeloid leukemia (AML) relapse., Regional Oncology Research Center

OpenAlex ID: W4390615941

FWCI: 3.707

Cites: 15

Cited by: 12

Related to: 10